To the Editor:
Mycobacterium abscessuscomplex species are rapid-growing non-tuberculous mycobacteria (NTM) with multiple drug resistance profiles [1]. Increasing prevalence in cystic fibrosis (CF) subjects [1] may reflect several factors, including improved detection and increased CF survival. Persistent NTM infection post-transplantation is associated with poorer outcome [2], and the risk is highest withM. abscessus[3]. However, recent small case series have suggested improved short-term post-transplantation outcomes may be achievable despite pre-transplantationM. abscessusinfection [3]. The current approach to listing varies markedly across transplant centres and refusal to consider transplantation in those with active infection is common. Recent data have suggested a stratified approach to transplant listing for CF subjects withBurkholderia cepaciacomplex may be appropriate, as poor outcomes were attributable to genomovar III (B. cenocepacia) alone [4].
Recently,M. abscessushas been recognised to be a complex of three closely related species:M. abscessus(sensu stricto), hereafter referred to asM. abscessus,M. massilienseandM. bolletii, which are collectively termedM. abscessuscomplex [5]. The transplantation literature to date has not examined the impact ofM. abscessusspecies type on outcome. In this case series we describe experience at a single paediatric lung transplant centre (Great Ormond Street Hospital, London, UK) with subjects infected withM. abscessuscomplex pre-transplantation and provide pilot data suggesting post-transplantation outcome may be influenced by the particularM. abscessuscomplex species encountered.
Five subjects have been transplanted since 2003 with activeM. abscessuscomplex infection at the time of listing, as defined by American Thoracic Society guidelines. Isolates, originally identified at the national reference laboratory, were retrospectively examined in-house toM. abscessuscomplex species level usinghsp65andrpoBgene sequencing methods, as previously published [6]. The intended management protocol was the same for all cases. Pre-transplantation, subjects received optimised multipleM. abscessuscomplex targeted therapy prior to listing (directed by sensitivity testing) to reduce NTM load for at least 6 months; at the time of transplantation, complete mediastinal and hilar lymphadenectomy, bilateral pleural cavity irrigatation with Amikacin solution (1 g diluted in 5 L of 0.9% saline) and change of surgical gloves prior to donor organ implantation; and post transplantation, individually tailoredi.v.multiple anti-infective drug regimens, continued for at least 4 weeks, before switching to long term prophylactic therapy (typically nebulised amikacin, oral ciprofloxacin and clarithromycin), continued indefinitely, as tolerated. Induction therapy with basiliximab was used at the time of transplant followed by a lifelong triple immunosuppressant regimen (tacrolimus, mycophenolate mofetil and prednisolone). Pre-transplant features and post-transplant course of these five cases are summarised (in chronological order) in [table 1.
Acceptable survival (four of five children, 80%) by the end of current follow-up (range 2.5–7.5 years) was achieved using this targeted management protocol, comparable with survival in non-NTM subjects at our institution (unpublished data). Furthermore, identification to species level suggested improved outcomes, with no re-isolation, in subjects with non-M. abscessusspecies ofM. abscessuscomplex pre-transplantation (i.e. M. massilienseandM. bolletii). In comparison, mortality and morbidity was encountered in two of the three subjects infected withM. abscessus (M. abscessus sensu stricto). Direct attribution of mortality toM. abscessusfor case four is difficult butpost mortemexamination documented the cause of death as “overwhelming sepsis secondary to organisms includingM. abscessus” (others isolated werePseudomonas aeruginosaand candida). Histology did not show granuloma in the graft butM. abscessus从气管,支气管胸膜和肺吗post mortem. This pattern of risk has never been described before in transplant subjects.
Other factors contributing to recurrence risk include mycobacterial load, viability and colony morphotype at the time of transplant, and the ability to surgically remove all infected foci. While eradication of infection pre-transplantation is unlikely, reduction of viable organisms may be achievable. Failure to achieve sputum smear negativity in the one patient withM. abscessuswho did not survive the initial post-operative period (case four) suggests a higher NTM load at the time of transplantation. A “rough” colony morphotype, associated with increased virulence [7], was persistently seen pre-transplantation in both cases with recurrence following (cases three and four). The surgical aim, to remove all infected foci using widespread lymph node excision, was not feasible in the two cases with recurrence (cases three and four), due to excessive bleeding, leaving mediastinal and hilar lymph nodesin situ. Granulomatous inflammation in excisable lymph nodes was not seen in either subject histologically, but these were not sent for culture so infection was not excluded. Contamination of the pleural space during explantation or by direct contiguous infection is a further risk factor and retrospective examination of computed tomography changes did not predict the degree of explantation difficulty in either case. Amikacin chest cavity wash out was employed as this antibiotic could be applied in high concentration with good prolonged effect (it binds to the cell wall and is active after free concentration is reduced). No efficacy studies are available on this treatment, but it was not used in the fatal case with persistent infection (case four).
In general oral or nebulised prophylactic NTM combinations were well tolerated, although side-effects of long-termi.v., oral and nebulised antibiotics were encountered, including bilateral hearing loss and chronic renal impairment. No clear recommendations about anti-NTM treatment duration exist in this setting. Clarithromycin-based regimens may suppress disease, and combination therapy is recommended [1]. Due to lifelong immunosuppression, we continued prophylactic treatment if tolerated. Choice of anti-NTM antibiotics was limited byin vitrosensitivity data suggesting resistance to most agents tested in all isolates, although there were variable results with different isolates over time (data not shown). Agents with evidence of activity were usually clarithromycin, tigecycline and amikacin. Synergy testing had not been performed.
In summary, acceptable post-transplant outcomes in subjects infected withM. abscessuscomplex can be achieved with four out of five, or 80%, survival to date, in this the longest follow up study to date in the literature, comparable with non-NTM subjects at our institution. These findings have important implications for CF subjects referred for lung tranpslant with activeM. abscessus复杂的感染,我们相信active infection should not be seen as a contraindication for transplantation. Risk stratification may be warranted inM. abscessuscomplex, as was recently described forBurkholderia cepaciacomplex [4], with greater risk in those colonised withM. abscessus (sensu stricto)and lower risk with other species. These pilot data do not directly test this hypothesis and direct testing with multicentre retrospective data is challenging given the low rate of transplantation listing of these subjects; of 5200 screened transplant cases, only two out of 17 with post-transplantation infection had isolated pre-transplant [8]. Our hypothesis is supported, however, by improved treatment response withM. massiliensein immunocompetent hosts, attributed to a lack of inducible clarithromycin resistance [9]. Inducible clarithromycin resistance varies between strains ofM. abscessus[10] and although the clinical significance is not confirmed, it warrants study as a potential prognostic factor. The role of morphology and NTM load at transplantation also requires further study. Multicentre efforts to identifyM. abscessuscomplex isolates to this degree, increased consideration of these subjects for transplantation, and pooling of both future and retrospective data will be required in the future to formally test this hypothesis.
Acknowledgments
The authors would like to acknowledge the contribution that Dr Silvija Jerkic made as a collaborator in the early data collection for this study.
Footnotes
Statement of Interest
None declared.
- ©ERS 2013